首页> 外文期刊>Nephron >Renal TLR4 mRNA expression correlates with inflammatory marker MCP-1 and profibrotic molecule TGF-beta in patients with chronic kidney disease.
【24h】

Renal TLR4 mRNA expression correlates with inflammatory marker MCP-1 and profibrotic molecule TGF-beta in patients with chronic kidney disease.

机译:慢性肾脏疾病患者的肾脏TLR4 mRNA表达与炎症标志物MCP-1和纤维化分子TGF-β相关。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Toll-like receptor-4 (TLR4) has been implicated in the pathogenesis of different renal diseases in rodent models. However, in human kidney disease, TLR4 expression and regulation is not well understood. We hypothesized that renal TLR4 expression plays a role in chronic kidney disease (CKD) and is associated with proteinuria, kidney function, histological diagnosis, and inflammatory mediators. METHODS: We quantified TLR4 mRNA as well as expression of macrophage chemoattractant protein-1 (MCP-1), transforming growth factor-beta (TGF-beta) and interleukin-6 (IL-6) in human kidney biopsies from 70 patients with CKD. We measured kidney function, urinary MCP-1 protein excretion, and the amount of chronic damage. Macrophage load was quantified by CD68 and vascularization by CD34 immunostaining. RESULTS: TLR4 expression correlated significantly with MCP-1 and TGF-beta expression. High TLR4 expression was associated with high IL-6 expression. TLR4 expression was significantly upregulated in patients with severe proteinuria, and in patients with chronic ischemic renal damage and IgA nephropathy, when compared to patients with thin glomerular basement membrane disease. TLR4 expression did not correlate with creatinine clearance, renal outcome, macrophage load or chronic damage. CONCLUSIONS: We show for the first time that renal TLR4 expression was significantly associated with the pro-inflammatory marker MCP-1 and the profibrotic molecule TGF-beta in kidney biopsies from patients with CKD, suggesting that increased expression of TLR4 is an important feature of CKD.
机译:背景:Toll样受体4(TLR4)与啮齿动物模型中不同肾脏疾病的发病机制有关。但是,在人类肾脏疾病中,TLR4的表达和调控尚不十分清楚。我们假设肾脏TLR4表达在慢性肾脏疾病(CKD)中起作用,并且与蛋白尿,肾脏功能,组织学诊断和炎症介质有关。方法:我们对70例CKD患者的肾脏活检组织中的TLR4 mRNA以及巨噬细胞趋化蛋白1(MCP-1),转化生长因子β(TGF-beta)和白细胞介素6(IL-6)的表达进行了定量。 。我们测量了肾脏功能,尿中MCP-1蛋白的排泄量以及慢性损伤的程度。通过CD68定量巨噬细胞负荷,通过CD34免疫染色定量血管化。结果:TLR4表达与MCP-1和TGF-β表达显着相关。高TLR4表达与高IL-6表达相关。与肾小球基底膜病患者相比,重度蛋白尿患者,慢性缺血性肾损害和IgA肾病患者中TLR4表达明显上调。 TLR4表达与肌酐清除率,肾预后,巨噬细胞负荷或慢性损伤无关。结论:我们首次显示肾脏CKD患者的肾脏活检中肾脏TLR4表达与促炎标记物MCP-1和纤维化分子TGF-β显着相关,这表明TLR4表达的增加是该病的重要特征。 CKD。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号